Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Pancreatic Cancer
67%
Gemcitabine
31%
Tumorigenesis
31%
Tumor
29%
Chemotherapy
27%
Pancreatic Duct Cells
20%
Oncogenic Ras
19%
Patient-derived Xenograft
19%
Metastatic Pancreatic Ductal Adenocarcinoma
18%
RalA
16%
Overall Survival
15%
Tumor Microenvironment
15%
Tumor Growth
15%
Nab-paclitaxel
15%
CCR2
14%
Transcriptome
14%
KRAS-mutant Cancer
14%
Extracellular Signal-regulated Kinase
14%
Chemoresistance
14%
Mitogen-activated Protein Kinase
14%
Colorectal Cancer
13%
NF-B
13%
Poor Prognosis
12%
Tumor Maintenance
12%
Cancer-associated Fibroblasts
12%
Resectable Pancreatic Cancer
11%
K-ras
11%
Gallbladder Cancer
11%
Oncogene
10%
RalB
10%
Targeted Treatment
10%
Inflammatory Pathways
10%
Tumor-associated Macrophages
10%
FOLFIRINOX
10%
Toll-like
10%
Gastrointestinal Cancer
10%
Cancer Patients
10%
Human Cancer
10%
Tumor Cells
9%
Pembrolizumab
9%
Phase Ib Study
9%
Neoadjuvant
9%
Comprehensive Characterization
9%
Metastatic Colorectal Cancer (mCRC)
9%
Liposomal Irinotecan
9%
Ulixertinib
9%
Diffuse Large B-cell Lymphoma (DLBCL)
9%
IRAK4
9%
Human Cells
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
78%
Pancreas Cancer
66%
Neoplasm
50%
Malignant Neoplasm
32%
Gemcitabine
30%
Chemotherapy
30%
Diseases
28%
Clinical Trial
21%
Carcinogenesis
18%
Tumor Growth
16%
Paclitaxel
16%
Progression Free Survival
16%
Drug Resistance
15%
Overall Survival
15%
Fluorouracil
14%
Folinic Acid
14%
Immunotherapy
12%
Bile Duct Carcinoma
12%
Digestive System Cancer
10%
Adenocarcinoma
10%
Mitogen Activated Protein Kinase
10%
Oxaliplatin
9%
Irinotecan Sucrosofate
9%
Ulixertinib
9%
Tumor Microenvironment
9%
Colorectal Carcinoma
8%
Gallbladder Cancer
8%
Focal Adhesion Kinase
8%
Janus Kinase 1
8%
Adverse Event
7%
Pancreas Carcinoma
7%
Mouse Model
6%
Phosphotransferase
6%
Receptor
6%
Side Effect
6%
Diarrhea
6%
Metastasis
6%
Irinotecan
6%
Biliary Tract Cancer
6%
Liver Cell Carcinoma
5%
Toxicity
5%
Focal Adhesion Kinase Inhibitor
5%
Toll Like Receptor 9
5%
Defactinib
5%
Fibrosis
5%
Medicine and Dentistry
Pancreas Adenocarcinoma
74%
Pancreas Cancer
56%
Neoplasm
46%
Diseases
21%
Gemcitabine
20%
Drive
15%
Overall Survival
14%
Malignant Neoplasm
14%
Clinical Trial
14%
Cancer
13%
Stroma
12%
Immunotherapy
12%
Metastatic Carcinoma
12%
Cholangiocarcinoma
12%
Hepatocellular Carcinoma
11%
Ras Signaling
10%
Radiation Therapy
10%
Progression Free Survival
10%
Chemokine Receptor
9%
Gastrointestinal Cancer
9%
Diffuse Large B-Cell Lymphoma
9%
Gallbladder Cancer
8%
Surgery
8%
Cancer Associated Fibroblast
7%
Adenocarcinoma
7%
Tumor Cell
7%
Positron Emission Tomography
7%
Nuclear Factor
7%
Alternative Complement Pathway C3 C5 Convertase
7%
Colorectal Carcinoma
6%
B Cell
6%
Systemic Therapy
6%
Phosphotransferase
6%
Proteomics
6%
Diagnosis
6%
Drug Resistance
6%
Cancer Types
6%
Mitogen-Activated Protein Kinase
6%
Biliary Duct Cancer
6%
Polyethylene Terephthalate
6%
Small GTPase
6%
Chemotherapy
5%
Tumor Progression
5%
Tumor Microenvironment
5%
Paclitaxel
5%
Fluorouracil
5%
Folinic Acid
5%
Oxaliplatin
5%
Cancer Therapy
5%
Fibrosis
5%